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Abstract                  1 
Aims/ Objectives 2 
To evaluate current literature via systematic review to ascertain whether amino acids/ 3 
vitamins provide any influence on musculotendinous healing, and by which physiological 4 
mechanisms.  5 
Methods 6 
EBSCO, PUBMED, Science Direct, Embase Classic/ Embase, and MEDLINE were searched 7 
using terms including “vitamins”, “amino acids”, “healing”, “muscle” and “tendon”.  The 8 
primary search had 479 citations, 466 of which were excluded predominantly due to non-9 
randomised design. Randomised human and animal studies investigating all supplement 10 
types/ forms of administration were included.  Critical appraisal of internal validity was 11 
assessed using the Cochrane risk of bias tool or the Systematic Review Centre for Laboratory 12 
Animal Experimentation (SYRCLE) risk of bias tool for human and animal studies, 13 
respectively. 2 reviewers performed duel data extraction. 14 
Results 15 
Twelve studies met criteria for inclusion: 8 examined tendon healing, 4 examined muscle 16 
healing. All studies used animal models, except 2 human trials using a combined integrator.  17 
Narrative synthesis was performed via content analysis of demonstrated statistically 18 
significant effects, and thematic analysis of proposed physiological mechanisms of 19 
intervention. Vitamin C/ taurine demonstrated indirect effects on tendon healing through 20 
anti-oxidant activity. Vitamin A/ glycine showed direct effects on extra-cellular matrix tissue 21 
synthesis. Vitamin E shows an anti-proliferative influence on collagen deposition. Leucine 22 
directly influences signalling pathways to promote muscle protein synthesis. 23 
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Discussion 24 
Preliminary evidence exists demonstrating vitamins and amino acids may facilitate multi-25 
level changes in musculotendinous healing; however recommendations on clinical utility 26 
should be made with caution. All animal studies and one human study show high risk of bias 27 
with moderate inter-observer agreement (k=0.46).  28 
Currently, there is limited evidence to support the use of vitamins and amino acids for 29 
musculotendinous injury. Both high quality animal experimentation of the proposed 30 
mechanisms confirming the physiological influence of supplementation; and human studies 31 
evaluating effects on tissue morphology and biochemistry are required before practical 32 
application. 33 
[299 words] 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
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Introduction 44 
Dietary supplements are defined as any concentrated source of a nutritional compound 45 
demonstrating a physiological effect (Department of Health, 2011). A meta-analysis (n=159) 46 
shows greater usage of supplements in athletes compared to non-athletes with increasing 47 
frequency in elite performers (Knapik et al., 2016). Despite heterogeneity between studies, 48 
a pooled prevalence estimate of 60% indicates high usage in the athletic population. 49 
Furthermore, supplement use guidelines are inadequate; athletes may misunderstand 50 
supplement effects; and display insufficient knowledge to independently plan their diet 51 
(Molinero & Márquez, 2009; Petróczi et al., 2007; Torres-McGehee et al., 2012). This may 52 
lead to disordered eating behaviours and in extreme cases may leave them at heightened 53 
risk of musculoskeletal injury such as fracture (Bonci et al., 2008).  Dietary management 54 
strategy can also be misinterpreted by coaches who discourage supplement use due to the 55 
potential risks of contamination and inadvertent doping (Judkins & Prock, 2012), but who 56 
have inadequate knowledge in nutritional practices to plan effectively during injury recovery 57 
(Tipton, 2011). Thus, leaving athletes reticent to supplement their diet during rehabilitation 58 
(Tack, 2016).  This is despite evidence from randomised controlled trials that supplements 59 
can provide therapeutic effects on muscle morphometry and strength following injury 60 
(Hespel et al., 2001; Holm et al., 2006); and muscular metabolic efficiency following 61 
immobility (Eijnde et al., 2001). A survey of 145 athletes demonstrated only 34% considered 62 
supplementation to improve musculoskeletal tissue repair (e.g. chondroitin, glucosamine, 63 
methyl-sulfonyl-methane and omega-3 fatty acids) (Malinauskas et al., 2007). In similar 64 
surveys, maintaining strength/endurance and avoiding sickness were more commonly cited 65 
reasons for supplementation (Petróczi et al., 2007a/b; Petróczi et al., 2008). 66 
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Animal experiments investigating skin wound healing indicate supplementation can elicit 67 
positive effects on collagen synthesis (Ejaz et al., 2009; Uzgare et al., 2009) and tensile 68 
breaking-strength (Shukla et al., 1999). More specifically, vitamins and vitamin-related-69 
compounds can increase growth factor release (retinoids) (Wicke et al., 2000); as well as 70 
enhancing tensile breaking-strength (vitamin E-like antioxidant, Raxofelast) (Galeano et al., 71 
2001). Other supplements, such as olive oil, can reduce oxidative damage during healing 72 
(Rosa et al., 2014); whilst the amino acid arginine can improve wound angiogenesis 73 
(Raynaud-Simon et al., 2012). The choice of supplement is therefore critical. Additionally, 74 
there is evidence of negative effects through excessive facilitation of pro-inflammatory 75 
pathways by omega-3 fatty acids (McDaniel et al., 2008); and in the case linseed and fish 76 
oils, of reduced tissue angiogenesis (Otranto et al., 2010). Human trials with arginine 77 
demonstrate improvements in blastogenic response to injury (Barbul et al., 1990; Sax, 78 
1994); and improved collagen deposition seen following supplementation with amino acid 79 
mixture containing arginine, beta-hydroxy beta-methylbutyrate and glutamine (Williams et 80 
al., 2002). Additionally, time to wound healing is reduced following supplementation of a 81 
mixture containing protein, zinc, iron and vitamin C (Collins et al., 2005).   82 
This review elaborates on a multi-topic feasibility search which incorporated all supplement 83 
types and the influence on musculotendinous tissue healing.  Subsequently a PICO 84 
(population, intervention, comparator, outcome) question was devised: “what is the effect 85 
of dietary supplements on musculoskeletal tissue (e.g. cartilage, tendon, muscle, ligament) 86 
healing compared to placebo or other control?”, and was used to formulate a search of 87 
Google Scholar and PUBMED to evaluate the quality/ volume of existing literature.   This 88 
search produced 95 papers which when assessed for eligibility was reduced to 24 studies.  89 
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Amino acids and vitamins demonstrated sufficient literature to perform a more specific 90 
systematic review and consequently these classifications of supplements encapsulated all 91 
literature found to evaluate the effect of supplements in muscle and tendon.  92 
The specific research question “what is the effect of vitamins and/ or amino acids on 93 
musculoskeletal tissue (e.g. cartilage, tendon, muscle, ligament) healing parameters 94 
compared to placebo or other control?” was then devised. This methodology (systematic 95 
review via content and thematic analysis) was chosen to synthesise findings of animal and 96 
human model experiments, previously undertaken in other areas of medicine (Sallis, 2000; 97 
Virmani et al., 2003), and in response to the call for methodologically sound reviews to 98 
evolve the research base (Reagan-Shaw et al., 2008).   99 
As such this review aims to identify whether these selected dietary supplements (amino 100 
acids and vitamins) provide any influence on muscle and tendon tissue healing in animal and 101 
human models of injury (traumatic, degenerative or exercise induced); and if so, what 102 
mechanisms underpin this influence. 103 
 104 
 105 
 106 
 107 
 108 
 109 
 110 
 111 
 112 
 113 
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 114 
 115 
 116 
 117 
 118 
 119 
Methods 120 
This review followed specific methodology guidelines (Centre for Reviews and 121 
Dissemination, 2009), and reported in accordance with the Preferred reporting items for 122 
systematic review and meta-analysis (PRISMA) statement for reporting systematic reviews 123 
(Moher et al. 2015).  The review was based upon an a priori protocol which described 124 
essential procedures to be followed (e.g. the PICO question of issue, comprehensive search 125 
strategy and a piloted data extraction pro forma).  126 
 127 
Eligibility Criteria 128 
This review followed the following inclusion criteria:  129 
• Randomised controlled trials of human and animal models of tendon and muscle 130 
injury. Although it has been reported that randomisation and blinding in animal 131 
studies is often not stringently adhered to (Hess, 2011); the choice was made to 132 
include these trials but be explicit in critique of these processes.  Despite continuing 133 
debate around the poor predictive value of animal experiments for humans 134 
(McGonigle & Ruggeri, 2014); this review includes animal models to support findings 135 
from human trials.  Methodological flaws (e.g. insufficient, allocation concealment/ 136 
blinding) (Kilkenny et al., 2009) can limit prediction from animals to humans (Hackam 137 
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& Redelmeier, 2006; Henderson et al., 2013); leading to problems such as outcome 138 
reporting bias (Tsilidis et al., 2013). To attenuate these risks (Sena et al., 2010) 139 
explicit application of randomisation and control group use is specified for inclusion. 140 
• Trials examining the influence of vitamins and/ or amino acid compounds applied 141 
orally, by injection or topically (either alone or in combination). 142 
• The studies must use outcomes indicative of physiological changes in healing (e.g. 143 
ultimate tensile strain, cellular tissue proliferation, and vascularisation). 144 
 145 
 Non-randomised trials were excluded to reduce selection bias (Hahn et al. 2005). Only 146 
English language papers were included due to a lack of translation services. Papers were 147 
initially screened by title/ abstract. Potentially relevant abstracts were sourced in full text 148 
and assessed independently against distinct inclusion criteria by two reviewers (CT/ FS) for 149 
eligibility. A third reviewer was available for consultation and consensus (LK). 150 
 151 
Non-randomised experimental or observational studies (including in vitro studies), and 152 
those investigating pharmaceutical drugs were excluded from the review. 153 
 154 
Search 155 
EBSCO, PUBMED, Science Direct and- via the OVID platform- Embase Classic/ Embase, 156 
MEDLINE and Global Health databases were searched from inception (1947) to 11th June 157 
2017.  158 
The following search field was used: (("muscle"[All Fields] OR "musculoskeletal"[All Fields] 159 
OR "tendon"[All Fields] NOT "cartilage"[All Fields] NOT "skin"[All Fields] NOT 160 
"cutaneous"[All Fields] NOT "bone"[All Fields]) AND ("Amino acid"[All Fields] OR 161 
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"vitamin"[All Fields] OR "arginine"[All Fields] OR "leucine"[All Fields] OR "phenol"[All Fields] 162 
OR "beta-Hydroxy beta-methylbutyric acid"[All Fields] OR "retinol"[All Fields] OR 163 
"ascorbic"[All Fields] OR "taurine"[All Fields])) AND ("healing"[All Fields] OR "repair"[All 164 
Fields] OR "collagen"[All Fields]) AND dietsuppl[sb]. 165 
Search terms were informed by a feasibility search, and in conjunction with a health 166 
information librarian. Citations of key articles found in the feasibility search were evaluated 167 
as a grey literature search. 168 
 169 
Data Extraction 170 
Data extraction was undertaken by two reviewers using a piloted form. Reasons for 171 
exclusion were noted. Data extraction included: date of study, animal or human model, type 172 
of tissue, subject details (animal type, age, sex), dosage and type of supplement (compound, 173 
administration or consumption), dosage and type of control or comparator, duration of 174 
supplementation, follow up times and losses to follow up, outcomes. 175 
 176 
Primary outcomes were pre-determined to be: 177 
- Histological changes to tissue collagen content or rate of synthesis 178 
- Biochemical changes in serum composition 179 
- Biomechanical alterations in force tolerance of healing tissue (e.g. ultimate tensile 180 
strength) 181 
 182 
Secondary outcomes were examined for clinical relevance and collected as appropriate (e.g. 183 
radiographic evidence of morphological change). 184 
 185 
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Data analysis 186 
Although the optimal synthesis method to strengthen findings of treatment effect from 187 
randomised trials is considered to be meta-analysis (DerSimonian & Laird, 1986) in this case 188 
it was deemed inappropriate as there was insufficient homogeneity of data across tissue 189 
types, interventions and outcomes to conform to data pooling. Instead a narrative synthesis 190 
was undertaken as per the method described by Popay et al. (2006) combining content 191 
analysis of the frequency of outcomes demonstrating statistically significant treatment 192 
effects, and thematic analysis of the mechanisms of identified effects. This method provides 193 
a framework appropriate for the analysis of intervention effectiveness when statistical 194 
means are not applicable (Rodgers et al., 2009); providing flexibility in structure to develop a 195 
theory of intervention effect by exploring relationships in the evidence base. This method 196 
has been applied previously with success (Arai et al., 2007) with conclusions similar to meta-197 
analysis on the same group of randomised trials (DiGuiseppi & Higgins, 2001). The 198 
comparison of narrative synthesis to meta-analysis on the same topic demonstrates the 199 
importance of using structure to maintain transparency of the process and establishes 200 
trustworthiness of the synthesis product by reducing selection bias (Rodgers et al., 2009). 201 
 202 
Critical Appraisal 203 
 204 
Evaluation of risk of bias was undertaken using the Cochrane risk of bias tool (Higgins et al., 205 
2011) for human studies or the Systematic Review Centre for Laboratory Animal 206 
Experimentation (SYRCLE) risk of bias tool for animal studies (Hooijmans et al., 2014). Two 207 
reviewers examined the studies for risk of bias and internal validity.  Specifically the 208 
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appraisers evaluated the studies relative to sources of bias (e.g. allocation concealment, 209 
blinding, selective outcome reporting) and classified to low, high or unclear risk of bias.  In 210 
order to assess inter-observer agreement of the risk of bias, the Kappa Statistic was used 211 
(Cohen, 1960).  212 
 213 
 214 
 215 
 216 
 217 
 218 
 219 
 220 
 221 
 222 
 223 
 224 
 225 
 226 
 227 
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 228 
 229 
Results           230 
Search 231 
Figure 1 presents the study selection process. Primary search results found 479 papers. 416 232 
articles were excluded after comparison against the research question, on the basis of title 233 
and abstract, with 63 remaining for evaluation of full text. 44 of these were excluded due to 234 
methodology inclusion criteria (non-randomised studies, narrative and systematic reviews); 235 
or due to examining incorrect tissue type (bone, cartilage, ligament, skin wounds). 7 were 236 
excluded on the basis of examining a supplement type different to amino acids/ vitamins 237 
(e.g. fatty acids), however these studies additionally had non-randomised designs. 12 238 
articles fulfilled the inclusion criteria. 239 
ADD FIGURE 1: PRISMA Flow diagram with the following:  
 
Figure 1. PRISMA flow diagram showing study selection process (Moher et al. 2009) 
 240 
 241 
Data Extraction 242 
Tables 1 and 2 provide a summary of the characteristics and findings of included studies. 8 243 
studies examined tendon healing (Table 1): 1 assessing vitamin A and E (Greenwald et al., 244 
1990); 2 assessing vitamin C (Hung et al., 2013; Ömeroğlu et al., 2009); 1 assessing taurine 245 
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(Akdemir et al., 2015); 2 assessing glycine (Vieira, Guerra et al., 2015; Vieira, De Oliveira et 246 
al., 2015), and 2 assessing nutrient complexes which included various supplements, (e.g. 247 
arginine, methylsulfonylmethane and vitamin C) (Gumina et al., 2012; Notarnicola et al., 248 
2012).  Only the integrator articles used human models. The animal experiments examined 249 
models of various injury types (e.g. incision/ repair, collagenase-induced, partial tear). 250 
Human studies examined surgical repair and tendinopathy models.  251 
4 studies examined the effect of leucine supplementation of muscle healing in animal 252 
models (Table 2). 2 studies examined healing following cryolesion, with the other studies 253 
examining exercise-induced muscle exhaustion and electrically-stimulated contraction-254 
induced injury.  255 
Tissue healing outcomes included biomechanical measures of tissue integrity; 256 
histopathological assessment of tissue via various procedures (e.g. immunostaining, 257 
biochemical assay, birefringence analysis); blood serum testing; and morphometric analysis 258 
(e.g. gross analysis of limb, microscopic examination of tissue).  259 
Quality Assessment 260 
All animal model studies demonstrated a high risk of bias. This was due to a number of 261 
common deficiencies in the methodological quality of these studies. For example, allocation 262 
concealment was not described in any of the papers, and as per the review decision rules 263 
lack of reporting was assumed to demonstrate failure to complete. Blinding was only 264 
undertaken in 1 paper (Kato et al., 2016), however this study did not randomise at the point 265 
of allocation and only prior to histochemical analysis. 2 studies (Vieira, De Oliveira et al., 266 
2015; Vieira, Guerra et al., 2015) randomised only prior to light microscopy analysis.  267 
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Of the two human studies, one was measured as a high risk of bias (Gumina et al., 2012) due 268 
to failure to blind assessors and complete intention-to-treat analysis. However, this study 269 
did demonstrate excellent randomisation and allocation concealment and undertook a 270 
power calculation to reduce likelihood of type II error. The other human study (Notarnicola 271 
et al., 2012) showed low risk of bias, due to computer-assisted randomisation/ allocation 272 
concealment, double-blinding, group matching of homogeneity and intention-to-treat 273 
analysis. 274 
Inter-observer agreement regarding the risk of bias was considered ‘moderate’ (k=0.46) 275 
according to the Viera and Garrett (2005) Kappa interpretation model.   Moderate interrater 276 
reliability may suggest an incorrect representation of the studies' risk of bias (McHugh, 277 
2012). However, with most studies demonstrating high risk of bias, caution is already 278 
suggested when generalising the results. 279 
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 Outcomes Summary 
Biomechanical Histopathological Biochemical Morphological FINDINGS RISK OF BIAS 
ANIMAL STUDIES 
Akdemir et al., (2015) 
 
Model: Rodent [Achilles 
tendon incision/repair] 
N= 16 
Supplement: Taurine 
 
Dosage: 200mg 
Taurine 
Route: Injection (x 1 
post repair) 
Control: Saline 
Follow up: 42 days 
Mean max load 
(p=0.025) 
 Mean max stress 
(p=0.025) 
 Mean energy uptake 
(p <0.05) 
(Verhodstd- modified 
score) 
 mean fibrosis, 
fibroblast proliferation (p 
<0.05), oedema. 
neutrophil infiltration 
(p <0.05) 
  Efficiency of tendon 
gliding improved over 
6 weeks with a 
reduction in tissue 
adhesion due to 
fibrosis, and increased 
biomechanical 
integrity. 
  
R1- High 
R2- High 
Greenwald et al., (1990) 
 
Model: Chicken [flexor 
profundus tendon 
incision/repair] 
N= 96 
Supplement: Vitamin A, 
E and beta-carotene 
 
Dosage: Vitamin A 
(150,000 IU/kg) (once 
daily for 45 days) 
Route: Oral  
Control: Standard 
chow (vit. A = 22,000 
IU/kg; vit. E = 35 
IU/kg; betacarotene 
= 1 mg/kg) 
Follow up: 7/ 45 days 
 UTS at 7 days 
(p=0.007), 30 days 
(p=0.06), 45 days 
(p<0.001) 
   Vitamin A elevates UTS 
during early healing, 
but perhaps at the risk 
of preventing true 
internal tendon 
strength. Conversely, 
vitamin E reduces UTS 
perhaps due to the 
reduction in peri-
tendon adhesions by 
anti-oxidant activity.  
Beta-carotene shows 
margin elevation of 
UTS. 
R1- High 
R2- High 
Dosage: Vitamin E 
(1000 IU/kg) 
[Otherwise as above] 
 UTS at 7 days 
(p=0.004), 45 days 
(p<0.001) 
   
Dosage: Beta-
carotene (90mg/kg) 
[Otherwise as above] 
Margin  UTS (p>0.05)    
Ömeroğlu et al., (2009)  
 
Model: Rodent 
[experimental Achilles 
rupture] 
N= 42 
Supplement: Vitamin C 
 
Dosage: 150mg 
vitamin C 
Route: Injection (post 
rupture and then 
every 2 days for 3- 21 
days 
Control: 1.5cc saline 
Follow up: 3/10/21 
days 
  revascularisation at 
day 3 (p=0.01) 
 collagen production at 
day 10 (p=0.021), day 21 
(p=0.103) 
 collagen diameter at 
day 3/10/21 (p<0.001) 
 fibroblast proliferation 
at day 3 (p=0.042) 
 
  Vitamin C facilitates 
histological changes in 
increased collagen 
proliferation and 
collagen fibre 
diameter, as well as 
increased numbers of 
fibroblasts. 
R1- High 
R2- High 
Vieira, De Oliveira et al. 
(2015)  
 
Model: Rodent 
[collagenase induced 
Achilles tendon injury] 
Dosage: 5% glycine 
diet, daily for 7-21 
days 
Route: Oral 
Control: Standard 
chow and water 
 UTS and maximum 
displacement load at 21 
days (p<0.05) 
 birefringence of 
collagen at 7 days  
 epitenon thickness at 
7 days (p<0.05) 
 GAGs at 7 (p<0.01) 
and 21 days (p<0.05)  
 hydroxyproline at 7 
and 21 days (p<0.05) 
 Glycine enhances 
tissue levels of GAGs, 
hydroxyproline and 
NCPs during early 
healing, leading to 
greater collagen 
R1- High 
R2- High 
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N= 50 
Supplement: Glycine 
 
Follow up: 7/21 days  NCPs at 7 days 
(reduced by 21 days) 
(p<0.01) 
synthesis and 
enhanced extracellular 
matrix re-modelling. 
Thus leading to greater 
biomechanical 
strength. 
Vieira, Guerra et al., 
(2015) 
 
Model: Rodent 
[collagenase induced 
Achilles tendon injury] 
N= 35 
Supplement: Glycine +/- 
green tea 
Dosage: Camellia 
sinensis (green tea/ 
GT) [700 mg/kg/day] 
+/- 5% glycine diet  
(daily for 7-21 days) 
Route: Oral, daily for 
7-21 days 
Control: Standard 
chow and water 
Follow up: 7/21 days 
 UTS at 21 days (GT and 
glycine) (p<0.05) 
 birefringence of 
collagen at 7 days (GT 
and glycine) (p<0.05) 
 
 GAGs at 21 days (GT 
and glycine) (p<0.05) 
 hydroxyproline at 7 
days (GT and glycine) 
and 21 days (GT only) 
(p<0.05) 
 NCP at 7 and 21 
days (GT and glycine) 
(p<0.05) 
 The combination of 
glycine and GT shows 
greater benefits to 
early collagen 
organisation at 7 days, 
leading to enhanced 
fibre stability and load 
tolerance. 
R1- High 
R2- High 
Hung et al., (2013) 
 
Model: Chicken 
[incisional injury to the 
flexor digitorum 
profundus tendon] 
N= 57 
Supplement: Vitamin C 
 
Dosage: Vitamin C 
(5mg/ml or 50mg/ml) 
Route: Injection 
immediately post 
injury 
Control: Saline 
Follow up: 14/ 42 days 
 tendon gliding 
resistance at 6 weeks 
(both dosages) (p=0.010) 
 swelling at 2 weeks 
(50ml) 
 tendon adhesions and 
fibrosis at 2 weeks (5ml) 
 glutathione at 2 
weeks (p=0.05) 
 fibrotic size at 6 
weeks (5mg) (p=0.013 
Vitamin C injection 
enhances anti-oxidant 
action, leading to 
reduced tendon 
adhesion and 
restoration of 
glutathione levels. 
There is a greater 
response for gliding 
resistance and fibrotic 
size with a lower dose 
(5mg). 
R1- High 
R2- High 
HUMAN STUDIES 
Gumina et al., (2012) 
 
Model: Human 
[Arthroscopic repair of a 
large postero-superior 
rotator cuff tear]  
N= 90 
Supplement: Combined 
integrator (Tenosan: 
arginine L-alpha-
ketoglutarate, 
methylsulfonylmethane, 
hydrolyzed type I 
collagen and bromelain) 
 
Dosage not given. 
Route: Oral (2 sachets 
per day for 12 weeks) 
Control: No 
supplement 
Follow up: 84 days 
    incidence of post 
repair classification type 
I-III (Sugaya’s 
classification) (p=0.045) 
 percentage re-
rupture (p=0.111) 
 percentage of type I-
II repair integrity 
(p<0.05) 
There is a higher 
incidence of type I-II 
classification of repair 
intensity and a 
reduced rate of re-
rupture in the 
intervention group. 
R1- High 
R2- Unclear 
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Notarnicola et al., 
(2012) 
 
Model: Human 
[Insertional Achilles 
tendinopathy] 
N= 64 
Combined integrator 
(Tenosan: 
arginine-L-alpha-
ketoglutarate (500 mg), 
MSM (550 mg), 
hydrolyzed collagen 
type I (300 mg), Vinitrox 
(125 mg), bromelain (50 
mg), and vitamin C (60 
mg). 
 
 Dosage:  
arginine-L-alpha-
ketoglutarate (500 
mg), MSM (550 mg), 
hydrolyzed collagen 
type I (300 mg), 
Vinitrox (125 mg), 
bromelain (50 mg), 
and vitamin C (60 mg 
[+ extra-corporeal 
shockwave therapy] 
Route: Oral (2 sachets 
per day for 60 days) 
Control: Placebo  
[+ extra-corporeal 
shockwave therapy] 
Follow up: 6 months 
   mean oximetry 
value at 6 months 
(p<0.0001) 
 Despite small effect 
sizes, the findings 
suggest ECSWT and a 
combined integrator 
can reduce tissue 
perfusion at 6 months 
in Achilles 
tendinopathy. 
R1- Low 
R2- Unclear 
Table 1 
Summary of study characteristics and findings of selected supplements on tendon healing 
 
[UTS- Ultimate tensile strength           GAGs- Glycosaminoglycans            NCP- Non-collagenous proteins                   MSM- Methylsulfonylmethane                   R1- Reviewer 1 [CT]                R2- Reviewer 2 [FS] 
ECSWT- extra-corporeal shockwave therapy 
 280 
 281 
 282 
 283 
 284 
 285 
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 Outcomes Summary  
 Biomechanical Histopathological Biochemical Morphological FINDINGS RISK OF BIAS 
ANIMAL STUDIES 
Anthony et al., (1999) 
 
Model: Rodent 
[exercise induced 
exhaustion of 
gastrocnemius/ 
plantaris] 
N= 30 
Supplement: Leucine 
Dosage: a) Leucine + 
exercise (54g/L), b) 
Leucine (54g/L) + 
exercise + 
carbohydrate (235.5g 
glucose/ 235.5g 
sucrose)  
Route: Oral diet 
provided immediately 
post exercise.  
Control: c) Sedentary 
control (no 
supplement), d) 
Exercise + dietary 
deprivation, e) 
exercise + 
carbohydrates (262.5g 
glucose/ 262.5g 
sucrose) 
Follow up: (outcomes 
taken 1 hour post 
eating) 
 
  fractional rate of 
protein synthesis  
[Protein synthesis 
elevated to the same as 
non-exercise controls 1 
hour after exercise]  
(leucine +/- 
carbohydrates) (p<0.05) 
 recovery of skeletal 
muscle glycogen 1 
hour post exercise 
(carbohydrate +/- 
leucine only) (p<0.05) 
 
 plasma insulin and 
muscle glycogen 
(carbohydrate + 
leucine) vs 
carbohydrate only 
(p<0.05) 
 Leucine may stimulate 
protein synthesis by 
enhancing muscle 
sensitivity to available 
insulin immediately 
after ingestion. Leucine 
works independently to 
stimulate protein 
synthesis (almost as 
effectively as leucine 
combined with 
carbohydrate) despite 
not raising insulin 
levels.  
R1- High 
R2- High 
Kato et al., (2016) 
 
Model: Rodent 
[electrically stimulated 
tibialis anterior 
contractions] 
N= 49 
Supplement: Leucine 
 
 
 
Dosage: Essential 
amino acids: leucine 
(1g/kg) 
Route: Oral (2 days 
pre-exercise and 1-14 
days post) 
Control: Oral saline 
gavage 
Follow up: 1-14 days  
 speed of return to 
stronger muscle 
function (3 days in 
leucine group) (p<0.05) 
 
Return of isometric 
dorsiflexion torque to 
the level of controls in 
14 days (leucine only) 
 numbers of damaged 
fibres (leucine) (p<0.001) 
 
 interleukin-6 
expression 1 day post 
exercise (leucine only) 
(p<0.001) 
 Provision of leucine 
enhances muscle 
healing by suppressing 
inflammation (indicated 
by reduced IL-6). Thus 
leading to attenuation 
of muscle damage and 
earlier return of muscle 
function following 
exercise. 
R1- High 
R2- High 
Pereira, Baptista et al., 
(2014) 
 
Model: Rodent [soleus 
muscle cryolesion] 
N=48 
Supplement: Leucine 
Dosage: Leucine 
(1.35g/kg) 
Route: Oral gavage (13 
days pre-injury, 10 
days post) 
Control: Oral saline 
gavage 
 reduction in strength 
production between pre 
and post fatigue tetanic 
stimulus (compared to 
the reduction shown in 
control animals) 
  myofiber cross 
sectional area at day 
10 (p<0.05) 
 inflammatory cell 
infiltration at day 10 
(p<0.05) 
 
 Leucine improves 
recovery of muscle 
fibre size and function 
(resistance to fatigue) 
post injury.  
The mechanism of 
these changes involves 
R1- High 
R2- High 
Page | 18 
 
 Follow up: 1-10 days  area density of 
collagen type III at day 
10 (p<0.05) 
 
 macrophage 
infiltration on day 3 
(p<0.05) 
 
 expression of 
mTOR/ p-mTOR at day 
10 (p<0.05) 
 
 activation of 
FOXO3a at day 3 and 
10 (p<0.05) 
Cryolesion-induced 
increase in ubiquinated 
protein was attenuated 
(p0.05) 
the protein 
ubiquination pathway. 
Changes include a slight 
reduction in mTOR 
expression (but no 
other alteration to the 
PI3K/Akt/ mTOR 
pathway); and reduced 
FOXO3a activation/ 
ubiquinated protein 
content. This would 
indicate reduced post 
exercise proteolysis. 
Pereira, Silva et al., 
(2014) 
 
Model: Rodent [tibialis 
anterior cryolesion] 
N= 22 
Supplement: Leucine 
Dosage: Leucine 
(1.35g/kg) 
Route: Oral gavage (13 
days pre-injury, 10 
days post) 
Control: Oral saline 
gavage 
Follow up: 10 days 
Prevention of reduction 
in pre-fatigued tetanic 
strength (however not 
sustained during fatigue 
protocol) 
 expression of 
phosphorylated TGF-beta 
receptor type-1 at day 10 
(p<0.05) 
 
 Smad2/3-positive 
nuclei at day 10 (p<0.05) 
 
 MyHC-n positive 
regenerating myofibers 
at day 10 (p<0.05) 
 
 MyHC-II at day 10 
(p<0.05) 
 
 hydroxyproline to 
levels of control (p<0.05) 
 
 fractional rate of 
protein synthesis 
(p<0.05) 
  procollagen/ thin 
collagen fibers. 
 
 inflammatory area 
(p<0.05) 
 
Leucine 
supplementation 
improves muscle 
contractile 
performance, without 
change in myofiber 
size. There is an 
accelerated shift from 
neonatal MyHC to adult 
MyHC and attenuation 
of proteins which 
promote excessive 
collagen synthesis.  
R1- High 
R2- High 
Table 2 
Summary of study characteristics and findings of selected supplements on muscle healing 
 
CSA- cross sectional area   FOXO3- Forkhead box O3    GAGs- glycosaminoglycans    IL-6- interleukin 6     MDA- malondialdehyde   mTOR- Mechanistic target of rapamycin   myHC-II- myosin heavy chain II (adult) 
NCP- non-collagenous proteins  TGF-β- transforming growth factor beta] 
286 
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Data Analysis 287 
Table 3 illustrates the results of the content analysis showing the common tissue healing 288 
outcomes and mechanisms of supplementation effect across studies. Outcomes with 289 
statistically significant effect only are displayed (p values <0.05). Whilst there is debate 290 
around the appropriate use of p-values as a measure of significance (Wasserstein & Lazar, 291 
2016), these tables aim to represent the key findings of the studies examined, rather than 292 
making any judgements as to the degree of intervention effect each supplement provides. 293 
This allows presentation of the large variability of heterogenous outcomes upon which the 294 
reviewer can base the theoretical examination of underlying mechanisms whilst reducing 295 
the probability of chance and providing evidence against the null hypothesis. Interestingly, 296 
inclusion of outcomes with no significant effect or negative effect did not influence the final 297 
conclusions in this review and were removed to focus the analysis. 298 
Thematic analysis indicates that various characteristics of tissue healing effect are shared 299 
across studies. Tables 1 and 2 delineate themes of the treatment effects by the outcomes 300 
presented in the studies (e.g. biomechanical, biochemical, etc.). However, as the content 301 
analysis displays only the outcomes chosen by the original researchers they may be open to 302 
publication bias, and other mechanisms may be possible. 303 
Themes were also extracted relative to when mechanisms were observed within normal 304 
healing phases (Watson, 2006) and are displayed in figures 2 and 3. Figure 2 illustrates that 305 
the changes in the extra-cellular matrix in response to tendon injury (beyond those seen in 306 
controls) occur predominantly throughout the inflammatory and proliferation phases of 307 
healing (within the first 21 days), but that changes are sustained into the remodelling phase 308 
(beyond 42 days). Morphological benefits remain evident for 6 months.  Figure 3 309 
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demonstrates that the mechanisms of effect in muscle tissue occur earlier and are 310 
commenced almost immediately (1 hour) post injury during the bleeding phase. 311 
Modification of muscle protein synthesis balance is then sustained during the inflammatory 312 
phases, where inflammation and oxidation is attenuated by supplementation. 313 
Further themes are apparent relative to how healing is influenced by supplementation, and 314 
patterns are observed relative to whether there is evidence of direct effects on cellular 315 
proliferation, or indirect physiological processes which precede healing. Of course, this 316 
observation is dependent upon which outcomes are used, but allows exploration of the 317 
effects of supplements on the response to injury.  Within tendon tissues, mechanisms 318 
include enhanced anti-oxidant action; control of immune response; and modification of 319 
elements of the extra-cellular matrix (ECM) content. The former effects (anti-oxidant action 320 
and immune response control) could be themed as indirect actions to cellular proliferation 321 
as they show changes which facilitate the tissues response to allow improved cellular 322 
regeneration, but do not directly cause cell synthesis. The latter mechanism (proliferation of 323 
ECM constituent components) includes increases in cellular components of collagen 324 
(hydroxyproline); balance of fibroblastic response; increases in glycosaminoglycan levels; 325 
reduction in non-collagenous proteins; and increases in the size and amount of collagen 326 
produced. These could be categorised as direct changes which facilitate proliferation and 327 
remodelling of regenerating tissue. In muscle healing, indirect mechanisms are also 328 
apparent (e.g. increased anti-oxidant or inflammatory action). However, rather than 329 
alterations to the extra-cellular matrix (as direct actions), biomechanical and muscular 330 
efficiency changes occur alongside promotion of plasma insulin sensitivity and a reduction in 331 
proteolysis. Following injury this would mean the number of damaged muscle fibres is 332 
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reduced, and there is improved functional rate of protein synthesis, leading to improved 333 
muscle tissue integrity, function and cross-sectional area. 334 
A final theme is apparent relative to the physiological level at which supplements act. The 335 
variety of outcomes show effects on tissue at a molecular biological level (e.g. biochemical 336 
or genetic change); a cellular biological level (e.g. protein signalling pathways); a 337 
histopathological level (e.g. tissue biopsy and microscopic evaluation); and a morphological 338 
level (e.g. radiological or clinical examination).  The themes show the supplements 339 
contribute to healing at various cellular levels, at various times alongside the healing phases, 340 
with both indirect and direct effects on the proliferation of tissue. As such there are a 341 
variety of outcomes which can be used to demonstrate their effect on healing and the 342 
structural integrity of the healing tissue.  343 
 344 
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TENDON 
  ↓ 
NCP 
↑ 
hydroxyproline 
concentration 
↑ 
GAGs 
↑ anti-
oxidant 
action 
(reduced 
MDA/ 
elevated 
glutathione) 
↑ fibroblast 
differentiation 
↓ immune 
cell response 
(macrophages, 
lymphocytes) 
↓ fibroblast 
proliferation 
↑ 
collagen 
diameter 
↑ collagen 
proliferation 
↓ 
swelling 
↑ tissue 
perfusion/ 
oximetry 
↓ 
UTS 
↑ UTS or 
mean 
maximum 
stress 
Morphologiical 
evidence of 
enhanced healing 
ANIMAL STUDIES 
Akdemir et al. 
(2015) 
 
Taurine               
Vieira et al (2015a) Glycine               
Vieira et al. (2015b) Glycine, 
green tea 
 
 
             
Greenwald et al. 
(1990) 
Vitamin A               
Greenwald et al. 
(1990) 
Vitamin E               
Ömeroğlu et al. 
(2009) 
Vitamin C               
Hung et al. (2013) Vitamin C               
HUMAN STUDIES 
Gumina et al. 
(2012) 
Combined 
integrator 
1 
              
Notarnicola et al. 
(2012) 
Combined 
integrator 
2 
              
Table 3 
 
Effects of supplementation on physiological parameters of healing in tendon and muscle tissue (statistically significant changes in response to intervention over control presented) 
 
 345 
 346 
MUSCLE   
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  ↑ plasma 
changes 
to insulin/ 
glycogen 
↓ 
interleukin 
6 
↑ MyHC-
II gene 
expression  
 
↓ transcription 
factor protein 
encoding 
relative to cell 
proliferation 
(mTOR, FOXO3) 
↓ 
Smad2/3 
+ nucleus 
↓ expression of 
phosphorylated 
TGF-β 
↓ 
hydroxyproline 
↓ 
ubiquinated 
protein 
↓ number 
of damaged 
fibres 
↑muscle 
strength or 
function 
↑ functional 
rate of protein 
synthesis  
↑ muscle 
CSA 
ANIMAL STUDIES 
Anthony et al. 
(1999) 
Leucine             
Kato et al. (2016) Leucine             
Pereira, Baptista 
et al. (2014) 
Leucine             
Pereira, Silva et 
al. (2014) 
Leucine             
Table 3 continued 
 
Effects of supplementation on physiological parameters of healing in tendon and muscle tissue (statistically significant changes in response to intervention over control presented) 
 
[Combined integrator 1- Arginine L-α- ketoglutarate, MSM, hydrolysed collagen I, bromelain      Combined integrator 2-  Arginine L-α- ketoglutarate, MSM, hydrolysed collagen I, bromelain, Vinitrox, vitamin C 
 
CSA- cross sectional area   FOXO3- Forkhead box O3    GAGs- glycosaminoglycans    IL-6- interleukin 6     MDA- malondialdehyde   mTOR- Mechanistic target of rapamycin   myHC-II- myosin heavy chain II (adult) 
NCP- non-collagenous proteins  TGF-β- transforming growth factor beta] 
 
 347 
 348 
 349 
 350 
 351 
 352 
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ADD FIGURE 2: Mechanisms of tendon issue change with the following: 
Figure 2. Graphical representation of mechanisms of supplement effect on tendon tissue relative to musculoskeletal healing phases 
(modified as described by Watson, 2006) 
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ADD FIGURE 3: Mechanisms of muscle tissue change with the following:  
Figure 3. Graphical representation of mechanisms of leucine effect on muscle tissue relative to musculoskeletal healing phases (modified as 
described by Watson, 2006) 
 353 
354 
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Discussion           355 
This review shows that specific amino acids (leucine, glycine, taurine) and vitamins (A, E and 356 
C) provide particular effects on the physiology of musculoskeletal tissue healing. These 357 
mechanisms occur at multiple levels (from molecular physiology to morphological tissue 358 
structure) and influence cell regeneration directly (cell proliferation) and indirectly (cellular 359 
environment enhancement). These changes occur alongside improvements in 360 
biomechanical integrity. The findings are predominantly guided by animal experiments, due 361 
to the ethical difficulties of performing histological examination of human tissue. The 362 
mechanisms described are indicative of the outcomes which demonstrated a degree of 363 
statistical significance, and perhaps do not outline all potential mechanisms. Similar effects 364 
in skin and experimental models are provided as comparative effects, with awareness that 365 
specific regenerative effects are dependent upon the host tissue cells. 366 
 367 
A number of studies describe effects on anti-oxidant capacity of the supplements as an 368 
indirect influence on tendon healing. Two studies (Hung et al., 2013; Ömeroğlu et al., 2009) 369 
examined vitamin C and its role as a free radical scavenger (Buettner & Moseley, 1993). In 370 
the presence of reactive oxygen species, vitamin C donates two electrons to reduce the free 371 
radical, and a less reactive ascorbyl radical is released.  Ömeroğlu et al. (2009) examined a 372 
rodent model of Achilles tendon rupture and provided injections of 150mg vitamin C every 373 
other day for 21 days. In comparison to saline injections the study found that vitamin C 374 
increased tissue perfusion in the early proliferative phase of healing alongside increased 375 
fibroblast proliferation (3 days post). At 10 and 21 days, collagen proliferation and diameter 376 
is elevated, and at 43 days tendon swelling is less. This may indicate an early healing 377 
response, leading to elevated collagen development and longer term benefits. Hung et al. 378 
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(2013) demonstrated reductions in fibroblast proliferation at 10 and 43 days (corresponding 379 
with the findings of greater balance between collagen formation and fibrosis) and increased 380 
glutathione at 14 days, indicating enhanced anti-oxidant action. These changes contributed 381 
to reduced fibrotic size and resistance to tendon gliding at 43 days.  The influence of a mixed 382 
anti-oxidant supplementation (including vitamin C) was measured in a double-blind, 383 
randomised, placebo controlled trial of trauma patients with non-musculoskeletal wounds 384 
(Blass et al., 2012). The results indicated that anti-oxidants (alongside glutamine) increased 385 
rate of healing by faster wound closure time in the supplement group versus placebo (35 386 
days ± 22 vs. 70 days  ± 35, p<0.01). Examination of topical vitamin C showed similar results, 387 
alongside increased collagen fiber density (p<0.05) (Lima et al., 2009). These results, 388 
alongside the findings of this review, demonstrate an apparent anti-oxidant mechanism to 389 
promote similar enhancement of healing in tendon.  390 
 391 
Another anti-oxidant is taurine; an amino acid which has been found to regulate collagen 392 
production and inhibit fibrosis (Gordon et al., 1986). A controlled animal study examined 393 
taurine’s effect on skin wound tensile strength and malondialdehyde (MDA) content- a 394 
measure of lipid peroxidation and oxidative stress following injury (Abuja and Albertini, 395 
2001; Dinçer et al., 1996). The results demonstrate taurine enhanced wound content and 396 
strength relative to histological evidence of enhanced collagen production and greater force 397 
displacement (p<0.01), and that topical application reduced MDA content more than 398 
injection. It could be suggested that increases in wound strength are secondary to increased 399 
anti-oxidant capacity and collagen synthesis, and assisted by taurine’s ability to aid vitamin C 400 
metabolism (Kaplan et al., 2004). Akdemir et al. (2015) examined the effect of 200mg 401 
taurine injections post rodent Achilles tendon repair, measuring UTS and histopathological 402 
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assessment after 42 days. Their results found reductions in immune cell activity, reduced 403 
fibroblast proliferation/ increased fibroblast differentiation, and increased UTS compared to 404 
saline control. The authors suggest taurine may reduce fibrosis and elevate repair integrity, 405 
and postulate this is due to both anti-oxidant and anti-inflammatory effects, and inhibition 406 
of fibronectin expression and fibrin formation during healing. This suggests that the 407 
influence of taurine on tendon wounds, is at least in part, in concurrence to the findings in 408 
skin wounds.  409 
Other supplements included in this review demonstrate more direct influences on tendon 410 
healing. Previous work by Ehrlich et al. (1973) examined the effect of vitamin A on the 411 
restoration of hydroxyproline content and histological tissue grading after provision of 412 
gluticorticoid which inhibits collagen synthesis and connective tissue repair. A rodent model 413 
of implanted polyvinyl sponge granuloma was used with sub-grouping into control, corticoid 414 
alone, vitamin A alone and combined corticoid and vitamin A. Injection was the route of 415 
administration for all groups. The results indicated vitamin A was able to partial reverse 416 
declines in fibroblast, collagen and hydroxyproline content diminished by gluticorticoid 417 
injection. Previous work by the same authors show that healing rate of skin wounds, not 418 
inhibited by cortisone, is not enhanced by vitamin A provided topically or via intramuscular 419 
systemic administration (Hunt et al., 1969). There is therefore some confusion as to whether 420 
vitamin A can influence collagen accumulation. One study in this review examined the 421 
effects of vitamins A (150,00 IU/kg) and E (1000 IU/kg) in a model of tendon repair healing 422 
in chickens (Greenwald et al., 1990). The animals were given daily oral doses and ultimate 423 
tensile stress (UTS) was evaluated at 7 and 45 days post repair. The results show an increase 424 
in UTS at both 7 days (897g +/- 164 vs. 356g +/- 68, p<0.007) and 45 days (1972g +/- 255 vs. 425 
Page | 29 
 
915g +/- 113, p<0.001) which supports the findings of Ehrlich et al. (1973), however without 426 
concurrent histopathological evidence of collagen change, this is speculative.  427 
A systematic review examining the effectiveness of vitamin E on measures on cell 428 
proliferation, infection and wound healing found a dearth of robust studies in this area 429 
(Hobson, 2016). This is despite the search finding a high number of primary research studies 430 
(n=31) and representing a reasonable level of quality (level 2b). Greenwald et al. (1990) 431 
found a reduction in UTS compared to control at 7 (163g +/- 81 vs. 356 +/- 68, P<0.004) and 432 
45 days (445g +/- 125 vs. 915g +/- 113, p<0.001) indicating vitamin E has a deleterious 433 
influence on healing tendon.  Vitamin E has been shown to act as a lysosomal membrane 434 
stabiliser (Ehrlich et al., 1972). Lysosomes- organelles responsible for the enzymatic 435 
responses to injury to balance matrix regeneration (Stromberg et al., 1977)- have been 436 
found to inhibit tendon healing (Ehrlich et al., 1972) leading to a reduction in collagen cell 437 
number and decreased UTS. It is possible that similar mechanisms may explain these 438 
results.   439 
Dietary arginine above recommended daily allowance has been shown to increase collagen 440 
accumulation in healthy animals (Barbul et al., 1990; Kirk et al., 1993). This review found no 441 
studies investigating the effect of this amino acid in animal models. Two human studies 442 
examined the effects of arginine L-α-ketglutarate within a combined integrator. The studies 443 
examined the effect of the supplement on rotator cuff repair integrity (Gumina et al., 2012); 444 
and tissue oximetry in Achilles tendinopathy (Notarnicola et al., 2012). Gumina et al. (2012) 445 
combined arginine with methylsulfonylmethane, hydrolysed collagen I and bromelain, for a 446 
dosing period of 12 weeks. Subsequently, they evaluated repair integrity in the intervention 447 
group against a no-supplement control and found a higher incidence of more favourable 448 
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Sugaya classification type I-II repair intensity (Sugaya et al., 2007); and a lower rate of re-449 
rupture.  Unfortunately, whilst the trial randomised and concealed allocation, they failed to 450 
report the dosage of supplements provided in the integrator. Additionally, the trial did not 451 
incorporate drop outs to the final analysis and failed to utilise a placebo control, and 452 
subsequently demonstrates a high risk of bias.  453 
 454 
Polytetrafluoroethylene implants allow researchers to evaluate deposition of fibroblasts and 455 
extracellular matrix tissue. A double-blind trial (Williams et al., 2002) randomised healthy 456 
adults (n=18) to receive daily amino acids (14g arginine, 3g HMB, 14g glutamine) or an 457 
isonitrogenous, isocaloric control supplement of non-essential amino acids. Implants 458 
removed at 7 or 14 days were analysed for hydroxyproline and amino-nitrogen. Whilst no 459 
significant differences in collagen accumulation (measured by hydroxyproline) were evident 460 
at 7 days, at 14 days there were significant increases in hydroxyproline content accumulated 461 
(+67%, p<0.03); occurring independent of an increase in total protein deposition. Evidence 462 
from elderly humans (Kirk, 1993) supports these results, demonstrating a 52% collagen 463 
increase, via a pro-inflammatory mechanism of action and enhancement of fibroblastic 464 
synthesis. During healing fibroblasts stimulate collagen synthesis deposition within the ECM 465 
(Stechmiller et al., 2005); and the production of growth factors (e.g. insulin-like growth 466 
factor 1, transforming growth factor β) promotes proliferation, angiogenesis and protein 467 
synthesis (Schultz & Mast, 1998). During the remodelling phase fibroblasts produce ECM 468 
components (collagen, gelatin and proteoglycans), and release metalloproteinases and 469 
tissue inhibitors of metalloproteinases to orchestrate tissue remodelling (Bryant, 2000; 470 
Schultz & Mast, 1998; Tarnuzzer & Schultz, 1996). 471 
Page | 31 
 
The other human study in this review (Notarnicola et al., 2012) used the same combined 472 
integrator, however also added 60mg vitamin C.  Subjects (n=64) were randomised and 473 
matched for age and gender and the integrator (or placebo) was provided orally for 60 days 474 
with or without extra-corporeal shockwave therapy (ESWT). The findings show that the 475 
supplement/ ESWT group had a reduced oximetry value at 6 months indicating a reduction 476 
in tendon micro-circulation and neovessel development; a component of the 477 
pathophysiology of tendinopathy (Knobloch, 2008). This study demonstrates a low risk of 478 
bias as it appropriately used randomisation, blinding, allocation concealment, intention-to-479 
treat analysis and group matching for homogeneity. However, for both studies using the 480 
combined integrator, effects are confounded by the use of multiple ingredients and caution 481 
is needed in extrapolating these results.  482 
 483 
The final supplement which evaluated an effect on tendon tissue is glycine; an amino acid 484 
synthesised by other amino acids, including hydroxyproline. Experiments demonstrate 485 
glycine’s capacity to prevent inflammatory cell infiltration and reduce joint oedema 486 
following injuries of experimental arthritis (Li et al., 2001). It is proposed that this anti-487 
inflammatory effect involves glycine receptor activation in leukocytes and suppression of 488 
immunocytes (Li et al., 2007).  Two studies (Vieira, De Oliveira et al., 2015; Vieira, Guerra et 489 
al., 2015) assessed the effect of glycine (with or without green tea) in a rodent collagenase-490 
induced Achilles' tendon injury model.  Each provided a 5% glycine diet and showed 491 
increases in collagen proliferation, alongside elevated hydroxyproline, non-collagenous 492 
protein content and glycosaminoglycan content at 7 days.  Hydroxyproline, 493 
glycosaminoglycans (GAGs) and non-collagenous proteins (NCPs) are components of the 494 
extracellular matrix. Hydroxyproline is a dominant protein of the ECM, comprising 20% of 495 
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fibrillary collagen structure; contributing to its molecular stability (Mouw et al., 2014). The 496 
non-collagenous matrix consists of GAGs (and other molecules including glycoproteins, 497 
proteoglycans) which surround collagen fibrils and bind water to assist mechanical tolerance 498 
to stress (Kannus, 2000). Increased tendon content of these ECM constituents, through 499 
glycine supplementation, may enhance collagen synthesis during the early proliferation 500 
phase, augmenting tensile strength. The addition of green tea to the glycine diet seems to 501 
enhance collagen organisation at 7 days leading to further fibre stability and load tolerance.  502 
 503 
In vivo and in vitro experiments indicate that the branched chain amino acid leucine acts as 504 
a signalling molecule to regulate protein synthesis in skeletal muscle (Anthony, Anthony et 505 
al., 2000; Kimball & Jefferson, 2001; Norton & Layman, 2006).  Leucine effects at a 506 
posttranscriptional level as a critical regulator of mRNA translation initiation (Anthony et al., 507 
2001) which facilitates protein synthesis (Svanberg et al. 1997, Yoshizawa et al., 1998). The 508 
role of mammalian target of rapamycin (mTOR) signalling is essential for translation 509 
initiation (Anthony, Yoshizawa et al., 2000).  Leucine facilitates an initial release of insulin 510 
(or increased insulin sensitivity in muscle); alongside a signalling cascade independent of 511 
phosphoinositol 3-kinase (PI3-K), protein kinase B (PKB/ Akt) or 3-phosphoinositide 512 
dependent protein kinase 1 (PDK1) activation (Anthony et al. 2001).  At mTOR these 513 
processes facilitate optimal activation of translation initiation, and are fine-tuned by other 514 
unidentified pathways (Anthony et al., 2001).  Four studies found in this review evaluated 515 
the effect of leucine on healing muscle tissue (Anthony et al., 1999; Kato et al., 2016; 516 
Pereira, Baptista et al., 2014; Pereira, Silva et al., 2014). The studies outline a process of an 517 
immediate response in the bleeding phase to attenuate inflammation and increase protein 518 
synthesis, starting with increased serum insulin and glycogen within one hour and elevated 519 
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fractional rate of protein (FRP) synthesis (Anthony et al., 1999). Reduction of the pro-520 
inflammatory cytokine, interleukin-6, occurs alongside reduction in muscle fibre damage. 521 
Subsequently, cross sectional muscle area is increased, with reduction in protein 522 
ubiquination; reduction in hydroxyproline as a proxy for reduced collagen; and modification 523 
of transcription signalling pathways to attenuate cell proliferation (e.g. expression of 524 
phosphorylated TGF-beta/ reduced Smad2/3+ nucleus).  Pereira, Baptista et al. (2014) 525 
identify that the reduction in mTOR expression occurs without other changes to the PI3K/ 526 
Akt/ mTOR pathways and that the change in FOXO3a expression is indicative of reduced 527 
post exercise proteolysis. Additionally, Pereira, Silva et al., (2014) also demonstrates a 528 
genetic shift towards adult Myosin Heavy Chain which assists muscle action. Alongside the 529 
leucine-assisted changes to collagen synthesis, this may suggest a fine tuning of healing 530 
response to ensure muscle contractile action is balanced with collagen formation. In 531 
summation leucine acts during bleeding/ early proliferation to enhance muscle 532 
regeneration. 533 
 534 
Implications/ Limitations 535 
 536 
This review summarises potential mechanisms for how selected supplements can influence 537 
tendon and muscle healing, the basis of which are limited to the outcomes used by the 538 
original studies. As no consensus is clear across the literature, minimal recommendations 539 
can be given as to the clinical utility of such supplements for musculoskeletal healing. 540 
Clinicians should however remain cognisant of nutritional practices throughout 541 
rehabilitation, particularly in respect to the regenerative influences of vitamins and amino 542 
acids. 543 
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 544 
As the predominant source of this data is from animal models it is essential to reflect on 545 
their use to guide human consumption. Animal models can approximate human 546 
physiological response to injury (Woo & Buckwalter, 1988) and act as a test for wound 547 
healing agents (Gottrup et al., 2000). However, all animal studies analysed showed a high 548 
risk of bias, indicating common methodological shortcomings. Lack of blinding, 549 
randomisation, or simply poor reporting would be assisted by adherence to the Animals in 550 
Research: Reporting in vivo experiments (ARRIVE) guidelines (Kilkenny et al., 2009) and 551 
support future developments in research. Additionally, two articles are likely influenced by 552 
confounding variables; specifically extra-corporeal shockwave therapy (Notarnicola et al. 553 
2012) and the addition of green tea (Vierra, Guerra et al. 2015), which must be considered 554 
when evaluating supplement effects. An additional limitation of this research is that the 555 
search results did not produce evidence for effects of supplements commonly associated 556 
with recovery such as branched-chain amino acids (Negro et al., 2008; Sharp and Pearson, 557 
2010). This is likely due to the strict inclusion criteria of randomised trial design. As such this 558 
review may not sufficiently elucidate all mechanisms of tissue response to injury related to 559 
amino acids supplementation. 560 
 561 
Future Research 562 
 563 
High quality animal experimentation studies investigating the effects of supplements on 564 
molecular, cellular and whole tissue levels; utilising outcomes of histological evidence of 565 
tissue synthesis and biomechanical integrity; and at time points throughout the healing 566 
process, need to be conducted to elaborate further on these findings. Human studies should 567 
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concentrate on assessing the effectiveness of supplements compared to isocaloric/ 568 
isonitrogenous placebo and be investigated with clinical and radiological outcomes to 569 
evaluate whether the proposed mechanisms translate to practice. 570 
 571 
 572 
Conclusions         573 
Amino acids and vitamins demonstrate both indirect (anti-oxidant) and direct (synthesis rate 574 
modifying) mechanisms of action in healing of tendon and muscle in animal models. These 575 
mechanisms act at various stages of the healing cycle, and work on all physiological levels 576 
from molecular to morphological. The translation of these mechanisms in humans is 577 
speculative, however there is potential that supplements may provide some clinical utility. 578 
Further research is required to test these hypotheses.  579 
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